𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?

✍ Scribed by George N. Dalekos; Dimitrios P. Bogdanos; James Neuberger

Book ID
111237865
Publisher
John Wiley and Sons
Year
2008
Tongue
English
Weight
52 KB
Volume
28
Category
Article
ISSN
0106-9543

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

The model for end-stage liver disease sc
The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1–infected patients with end-stage liver disease: A prospective cohort study
✍ Javier Murillas; Antonio Rimola; Montserrat Laguno; Elisa de Lazzari; Javier Ras πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 149 KB πŸ‘ 1 views

End-stage liver disease (ESLD) has become the main cause of mortality in patients coinfected by human immunodeficiency virus (HIV) and hepatitis B virus or hepatitis C virus in developed countries. The aim of this study was to describe the natural history of and prognostic factors for ESLD, with par

Features associated with treatment failu
Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease
✍ Aldo J. Montano-Loza; Herschel A. Carpenter; Albert J. Czaja πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 179 KB

Autoimmune hepatitis may fail to respond to corticosteroid therapy, but the frequency and bases for this outcome are uncertain. We aimed to determine the frequency and nature of treatment failure in patients with type 1 autoimmune hepatitis, define features associated with its occurrence, and assess